Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S512)
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
This bill would ban tianeptine and similar dangerous products from being sold.
The problem
Tianeptine is a drug sold as dietary supplements or nootropics that causes addiction and health problems. It's not regulated like prescription medicines.
The proposal
The bill would prohibit manufacturing, selling, and distributing tianeptine and related substances. It would treat them as controlled or banned products.
The impact
Consumers who use these products would no longer access them legally. Retailers selling them would need to stop. Healthcare providers would handle more addiction cases.
Tianeptine causes severe addiction similar to opioids. Banning it would prevent new users from becoming addicted and reduce public health costs from treating addiction.
These products are often marketed to teenagers as legal supplements. A ban prevents teenagers from easy access to addictive substances.
Currently, tianeptine exploits gaps in supplement regulation. This bill strengthens federal oversight of dangerous products masquerading as safe supplements.
Tianeptine withdrawal causes severe symptoms requiring hospitalization. Eliminating the product reduces emergency medical costs and hospital burden.
Adults who use tianeptine for self-treatment would lose legal access. Some individuals believe they should choose their own treatments.
Supplement shops and online retailers currently selling these products would lose sales revenue. Enforcement could require inspection resources.
Banning products sometimes creates illegal black markets that are harder to monitor. This could make products less safe without health oversight.
The bill doesn't specify exactly which products are included or provide research justifying the ban. This could cause confusion during enforcement.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.